Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) – protocol for prospective cohort study

por Bogdanet, D., O’Shea, PM., Halperin, J., Dunne, F.
Publicado 2020

A core outcome set for the treatment of pregnant women with pregestational diabetes: an international consensus study

por Kgosidialwa, O, Bogdanet, D, Egan, AM, O′Shea, PM, Newman, C, Griffin, TP, McDonagh, C, O′Shea, C, Carmody, L, Cooray, SD, Anastasiou, E, Wender-Ozegowska, E, Clarson, C, Spadola, A, Alvarado, F, Noctor, E, Dempsey, E, Napoli, A, Crowther, C, Galjaard, S, Loeken, MR, Maresh, MJA, Gillespie, P, deValk, H, Agostini, A, Biesty, L, Devane, D, Dunne, F
Publicado 2021